Skip to main content

State-of-the-Art Genetic Programming for Predicting Human Oral Bioavailability of Drugs

  • Conference paper
Book cover Advances in Bioinformatics

Part of the book series: Advances in Intelligent and Soft Computing ((AINSC,volume 74))

Abstract

Being able to predict the human oral bioavailability for a potential new drug is extremely important for the drug discovery process. This problem has been addressed by several prediction tools, with Genetic Programming providing some of the best results ever achieved. In this paper we use the newest state-of-the-art developments of Genetic Programming, in particular the latest bloat control method, to find out exactly how much improvement we can achieve on this problem.We show examples of some actual solutions and discuss their quality from the practitioners’ point of view, comparing them with previously published results. We identify some unexpected behaviors and discuss the way for further improving the practical usage of the Genetic Programming approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Archetti, F., Lanzeni, S., Messina, E., Vanneschi, L.: Genetic programming for human oral bioavailability of drugs. In: Cattolico, M. (ed.) Proceedings of GECCO-2006, pp. 255–262 (2006)

    Google Scholar 

  2. Archetti, F., Messina, E., Lanzeni, S., Vanneschi, L.: Genetic programming for computational pharmacokinetics in drug discovery and development. Genetic Programming and Evolvable Machines 8(4), 17–26 (2007)

    Article  Google Scholar 

  3. Kennedy, T.: Managing the drug discovery/development interface. Drug Discovery Today 2, 436–444 (1997)

    Article  Google Scholar 

  4. Kola, I., Landis, J.: Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery 3, 711–716 (2004)

    Article  Google Scholar 

  5. Langdon, W.B., Barrett, S.J.: Genetic Programming in data mining for drug discovery. In: Evolutionary computing in data mining, pp. 211–235 (2004)

    Google Scholar 

  6. Poli, R., Langdon, W.B., McPhee, N.F.: A field guide to genetic programming. (With contributions by J. R. Koza) (2008), Published via, http://lulu.com and freely available at, http://www.gp-field-guide.org.uk

  7. Silva, S.: Controlling bloat: individual and population based approaches in genetic programming. PhD thesis, Departamento de Engenharia Informatica, Universidade de Coimbra (2008)

    Google Scholar 

  8. Silva, S., Costa, E.: Dynamic limits for bloat control in genetic programming and a review of past and current bloat theories. Genetic Programming and Evolvable Machines 10(2), 141–179 (2009)

    Article  MathSciNet  Google Scholar 

  9. Silva, S., Dignum, S.: Extending operator equalisation: Fitness based self adaptive length distribution for bloat free GP. In: Vanneschi, L., Gustafson, S., Moraglio, A., De Falco, I., Ebner, M. (eds.) EuroGP 2009. LNCS, vol. 5481, pp. 159–170. Springer, Heidelberg (2009)

    Chapter  Google Scholar 

  10. Silva, S., Vanneschi, L.: Operator Equalisation, Bloat and Overfitting - A Study on Human Oral Bioavailability Prediction. In: Rothlauf, F., et al. (eds.) Proceedings of GECCO-2009, pp. 1115–1122. ACM Press, New York (2009)

    Chapter  Google Scholar 

  11. Van de Waterbeemd, H., Rose, S.: The Practice of Medicinal Chemistry. In: Wermuth, L.G. (ed.), 2nd edn., pp. 1367–1385. Academic Press, London (2003)

    Google Scholar 

  12. Wishart, S.D., Knox, C., Guo, A.C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z., Woolsey, J.: DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research 34 (2006), doi:10.1093/nar/gkj067

    Google Scholar 

  13. Yoshida, F., Topliss, J.G.: QSAR model for drug human oral bioavailability. Journal of Medicinal Chemistry 43, 2575–2585 (2000)

    Article  Google Scholar 

  14. Zechman, E.M., Ranjithan, S.R.: Multipopulation Cooperative Coevolutionary Programming (MCCP) to Enhance Design Innovation. In: Beyer, H.G., et al. (eds.) Proceedings of GECCO-2005, pp. 1641–1648. ACM Press, New York (2005)

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Silva, S., Vanneschi, L. (2010). State-of-the-Art Genetic Programming for Predicting Human Oral Bioavailability of Drugs. In: Rocha, M.P., Riverola, F.F., Shatkay, H., Corchado, J.M. (eds) Advances in Bioinformatics. Advances in Intelligent and Soft Computing, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13214-8_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-13214-8_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-13213-1

  • Online ISBN: 978-3-642-13214-8

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics